CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Arcadia Biosciences, Inc.  (RKDA)
Other Ticker:  
 
 
Price: $3.9200 $-0.13 -3.210%
Day's High: $ 4.04 Week Perf: 0.00
Day's Low: $ 3.72 30 Day Perf: -22.99 %
Volume (M): 75 52 Wk High: $ 66.56
Volume (M$): $ 296 52 Wk Avg: $ 8.15
Open: 4.04 52 Wk Low: 0.18
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 19
 Shares Outstanding (Millions) 5
 Employees 47
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -16
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0
Arcadia Biosciences, Inc.
We, a corporation formed in 2002, are an agricultural biotechnology trait company engaged in the development of traits that improve food, feed and fiber crops and enhance the value of the resulting agricultural products. Our customers include seed companies who incorporate these traits into their elite varieties to increase the value of a crop for farmers, as well as food and feed companies who make products that increase the choices and nutritional value of foods for consumers.


RKDA is expected to report next financial results on February 15, 2019.
 
  Company Estimates
  Revenue Outlook
Arcadia Biosciences, Inc. does not provide revenue guidance.

Earnings Outlook
Arcadia Biosciences, Inc. does not provide earnings estimates.

Geographic Revenue Dispersion

Innovus Pharmaceuticals, Inc.

Innovus Pharmaceuticals, Inc announced third quarter operating loss of $-1.502577 millions

Innovus Pharmaceuticals, Inc announced very strong Sales growth of 232.31 % year on year to $7.38 millions in the third quarter, but lost money at $-0.01.

Catasys, Inc.

Company Fail to Break-even Despite Surge in Sales

Catasys, Inc announced very strong Sales growth of 265.61 % year on year to $4.37 millions in the third quarter, but increased losses at $-0.27.

Novabay Pharmaceuticals, Inc.

Novabay Pharmaceuticals, Inc announced third quarter operating shortfall of $-1.809 millions

In the third quarter Novabay Pharmaceuticals, Inc decreased loss of $-0.11 per share compare to $-0.16 a year ago and improved from $-0.12 per share from the previous quarter.

Sales crumbled by -23.2 % to $3.14 millions from $4.09 millions in the same quarter a year ago and sequentially Sales advanced by 12.46 % from $2.79 millions.

Cesca Therapeutics Inc.

Cesca Therapeutics Inc announced third quarter operating loss of $-1.935 millions

Cesca Therapeutics Inc announced earnings per share of $-0.12 and Sales of $2.00 millions in the third quarter, Company's decreased loss per share, versus $-0.24 eps, earned in the same quarter a year ago, although Cesca Therapeutics Inc saw it's Sales rise by 1.43 % in the same period.

Procyon Corp

Procyon Corp announced first quarter operating profit of $0.12161 millions

In the first quarter Procyon Corp eps of $0.01 per share compare to $0.00 a year ago and eps soared by 63.34 % from $0.01 per share from the previous quarter.

Sales jumped by 31.23 % to $1.09 millions from $0.83 millions in the same quarter a year ago and sequentially Sales increased by 2.46 % from $1.06 millions.






Customers recorded net loss Customers recorded net loss
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
Major Competitors Stock performance

5 Days Decrease / Increase
     
CF   -9.82%    
MOS        0.11% 
IPHS   -6.13%    
FMC   -0.44%    
EMN        0.43% 
SANW        0.33% 
• View Complete Report
   



     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

UROV's Profile

Stock Price

UROV's Financials

Business Description

Fundamentals

Charts & Quotes

UROV's News

Suppliers

UROV's Competitors

Customers & Markets

Economic Indicators

UROV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071